FabiFlu | Zee News

Advertisement

FabiFlu News

11 May 2021

FabiFlu: Anti-Covid drug now top-selling pharma brand

FabiFlu registers 600 percent jump in sales for the month of April FabiFlu has topped the list of drugs with maximum sales value by recording Rs 762 crore sales

21 Jul 2020

Glenmark defends price of its COVID-19 drug favipiravir version

India`s drug regulator had reportedly sent the company a notice on overpricing. Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients. FabiFlu`s price is significantly lower than versions of favipiravir in other countries, the company added.

19 Jul 2020

DCGI queries Glenmark on FabiFlu use for COVID-19 patients with comorbidities

DCGI issued a notice to Glenmark Pharmaceuticals over its alleged "false claims" about the use of anti-viral FabiFlu on COVID-19 patients with comorbidities. Also, the "pricing" of the drug is in question after a Member of Parliament complained about the same.

Loading...

NEWS ON ONE CLICK